Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Protara Therapeutics, Inc (TARA)  
$3.34 0.10 (3.09%) as of 4:30 Tue 5/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 10,510,000
Market Cap: 35.10(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.125 - $4.83
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Protara Therapeutics is a clinical-stage biopharmaceutical company focused on identifying and developing transformative therapies for the treatment of cancer and rare diseases. Co.'s primary oncology program is TARA-002 in non-muscle invasive bladder cancer. Co. is also pursuing TARA-002 in lymphatic malformations, which are rare, non-malignant cysts of the lymphatic vascular system. The third development program in Co.'s portfolio is intravenous Choline Chloride, an investigational phospholipid substrate replacement therapy initially in development for patients receiving parenteral nutrition, who have intestinal failure associated liver disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 42,965
Total Buy Value $0 $0 $0 $159,618
Total People Bought 0 0 0 3
Total Buy Transactions 0 0 0 4
Total Shares Sold 182,300 182,300 182,300 197,773
Total Sell Value $566,950 $566,950 $566,950 $608,899
Total People Sold 1 1 1 1
Total Sell Transactions 2 2 2 3
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 196
  Page 5 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Opaleye, L.p. 10% Owner   –       –       •   2020-01-09 3 IO $0.00 $0 D/D 0 4,603     -
   Marshall Randall 10% Owner   –       –       •   2020-01-09 4 A $0.00 $0 D/D 654,020 654,020     -
   Zummo Jacqueline Sr. Vice President, Research   •       –      –    2020-01-09 4 A $0.00 $0 D/D 28,613 28,613     -
   Opaleye, L.p. 10% Owner   –       –       •   2020-01-09 4 A $0.00 $9,997,900 D/D 2,203,869 2,208,472     -
   Shefferman Jesse CEO and President   •       •      –    2020-01-09 4 A $0.00 $0 D/D 790,274 790,274     -
   Haines Timothy Former Director and 10% Owner   –       –      –    2019-11-12 4 OE $0.99 $125,999 I/I 126,645 2,144,517     -
   Abingworth Llp Former 10% Owner   –       –      –    2019-11-12 4 OE $0.99 $125,999 I/I 126,645 2,144,517     -
   Freund John Gordon Director   –       •      –    2019-11-08 4 OE $0.99 $700,000 D/D 703,588 2,175,882     -
   Burke Steven Keith SVP and Chief Medical Officer   •       –      –    2019-03-15 4 GA $0.00 $0 I/I 14,666 26,332     -
   Burke Steven Keith SVP and Chief Medical Officer   •       –      –    2019-03-15 4 GD $0.00 $0 D/D 22,000 101,917     -
   Kowalsky Matthew Paul VP, Legal and Secretary   •       –      –    2018-12-31 4 A $1.93 $4,725 D/D 2,448 29,479     -
   Eldridge George Arthur Sr VP, CFO, Treasr, Asst Secy   •       –      –    2018-12-31 4 A $1.93 $4,725 D/D 2,448 29,132     -
   Toner E. Scott Senior VP of Commercial   •       –      –    2018-12-31 4 A $1.93 $7,946 D/D 4,117 23,357     -
   Burke Steven Keith SVP and Chief Medical Officer   •       –      –    2018-12-31 4 A $1.93 $4,725 D/D 2,448 123,917     -
   Burke Steven Keith SVP and Chief Medical Officer   •       –      –    2018-06-29 4 A $1.62 $16,150 D/D 10,000 121,469     -
   Kowalsky Matthew Paul VP, Legal and Secretary   •       –      –    2018-06-29 4 A $1.62 $16,150 D/D 10,000 27,031     -
   Eldridge George Arthur Sr VP, CFO, Treasr, Asst Secy   •       –      –    2018-06-29 4 A $1.62 $16,150 D/D 10,000 26,684     -
   Toner E. Scott Senior VP of Commercial   •       –      –    2018-06-29 4 A $1.62 $7,842 D/D 4,856 19,240     -
   Noyes Timothy P President and CEO   •       •      –    2018-02-16 4 D $2.11 $6,324 D/D (2,997) 0     -
   Noyes Timothy P President and CEO   •       •      –    2018-02-15 4 D $2.15 $4,831 D/D (2,245) 2,997     -
   Noyes Timothy P President and CEO   •       •      –    2018-02-14 4 D $2.20 $7,700 D/D (3,500) 5,242     -
   Noyes Timothy P President and CEO   •       •      –    2018-01-16 4 D $2.36 $23,570 D/D (10,000) 8,742     -
   Toner E. Scott Senior VP of Marketing   •       –      –    2017-12-29 4 A $1.30 $7,168 D/D 5,531 14,384     -
   Burke Steven Keith SVP and Chief Medical Officer   •       –      –    2017-12-29 4 A $1.30 $5,098 D/D 3,934 111,469     -
   Eldridge George Arthur Sr VP, CFO, Treasr, Asst Secy   •       –      –    2017-12-29 4 A $1.30 $5,098 D/D 3,934 16,684     -
  196 Records found
  1  2  3  4  5  6  7  8   
  Page 5 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us